Pulmonology Devices Market by Product Type (Single-Use Forceps, Cytology Brushes, Microbiology Brushes), Endobronchial Ultrasound (Ebus) Needles [Endobronchial Ultrasound Fine Biopsy Needles, Endobronchial Ultrasound Transbronchial Aspiration Needles], Pulmonology Devices [Intensive Care Pulmonology Devices, Portable/Transportable Pulmonology Devices], Bronchoscopes [Video, Fiber], Airway Stents Systems, Oxygen Concentrators End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Others) by geography is predicted to expand at a steady CAGR forecast until 2030 due to the outbreak of the covid-19 pandemic and the increasing prevalence of respiratory disorders.

The global pulmonology devices market is expected to develop at a CAGR of 10.50% between 2024 and 2030. The Pulmonology Devices Market is growing due to rising incidences of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), bronchitis, lung cancer, the outbreak of the COVID-19 pandemic, increasing adoption of minimally invasive procedures, and rapid technological innovation in product development, all of which contribute to the market's growth from 2024 to 2030.

Get a Free Sample : https://www.zionmarketresearch.com/sample/pulmonology-devices-market

The COVID-19 epidemic has led to a major increase in demand for pulmonology devices. The need for Pulmonology Devices is currently expanding, as the populace has extensively used these devices to treat the dangerous condition.

The continued rise in COVID-19 cases around the world is predicted to increase demand for Pulmonology Devices significantly. For example, as of 14 February 2022, the World Health Organization (WHO) reported 410,565,868 confirmed cases of COVID-19.

Furthermore, the above data indicated that the five countries most badly affected by Covid-19 were the United States, India, Brazil, the United Kingdom, and France.

Furthermore, the introduction of novel strains, such as the Omicron form, which was first reported to WHO from South Africa on November 24, 2021, may enhance the use of Pulmonology Devices in various nations for early screening at home.

Furthermore, rising public awareness of the uses of Pulmonology Devices in COVID-19 management is expected to drive the Global Pulmonology Devices market.

Disease management improves when adequate systems are implemented. As a result, more COVID-19 instances are expected to drive up demand for Pulmonology Devices, adding to the market's growth between 2024 and 2030.

The rising global incidence of respiratory disorders is another factor driving the growth of the pulmonology devices market. Respiratory disorders are among the most common causes of death in the globe. According to the World Health Organization, chronic obstructive pulmonary disease (COPD) is the third greatest cause of death, accounting for 3.23 million deaths globally in 2019. According to the same figures, environmental exposure to tobacco smoke, indoor air pollution, and occupational dust, fumes, and chemicals are all significant risk factors for COPD. As a result, the growing number of COPD cases will help to drive growth in the Global Pulmonology Devices Market.

Furthermore, many companies have increased their manufacturing capacity to satisfy expanding demand. For example, in March 2020, Zoll Medical Corporation implemented a strategy to boost its manufacturing capacity to 10,000 Ventilators per month. This increased production volume aided in the treatment of COVID-19 patients, resulting in market expansion. It is also projected that the number of patients requiring breathing support will increase, as will demand for Pulmonology Devices, thereby hastening the market's expansion.

Certain issues, such as the complications connected with the use of invasive equipment and the high cost of endosurgical treatments, represent a slight impediment to the expansion of the pulmonology devices market.

Analysis of the Pulmonology Devices Market by Product Type: - Pulmonary Biopsy Devices (Single-use Forceps, Cytology Brushes, Microbiology Brushes) - Endobronchial Ultrasound (EBUS) Needles (Endobronchial Ultrasound Fine Biopsy Needles, Endobronchial Ultrasound Transbronchial Aspiration Needles) - Ventilators (Intensive Care Ventilators, Portable/Transportable Ventilators), Bronchoscopes (Video, Fiber), Airway Stents Systems, Oxygen Concentrator

The Portable/Transportable Ventilators subsegment of the Global Pulmonology Devices Market by Product Type is expected to grow the quickest from 2024 to 2030.

The high rise of this product area can be ascribed to its widespread use in hospitals, where it provides patients with convenience, speedier, and ongoing care even before they arrive on hospital grounds.

Since the start of the COVID-19 pandemic, the demand for portable ventilators has increased. As a result, the increasing demand for disease treatment helps the portable ventilator industry, even if the process is delayed.

Additionally, developers are developing lightweight, cost-effective ventilators to combat COVID-19. For example, in 2020, the Marico Innovation Foundation awarded Rs 85 lakhs to the winners of an innovation challenge for creating distinctive, disruptive, accessible, and cheap ventilators.

In addition, new product approvals are expected to boost the Ventilators market throughout the projection period. For example, in August 2021, Max Ventilator announced the introduction of the High Flow Oxygen Therapy (HFOT) device and WeanX to its new ventilator range category.

Furthermore, new/existing hospitals and healthcare centers in rural areas of developing nations such as India, China, and Brazil are being equipped with enhanced patient comfort amenities, which is predicted to increase market potential.

As a result, all of the aforementioned factors are likely to drive segment growth in the Ventilators market, as demand rises due to the increasing number of disorders that require breathing support.

North America is projected to lead the Pulmonology Devices Market during the forecast period. This dominance is attributed to the region's growing patient population suffering from chronic respiratory ailments such as asthma, Chronic Obstructive Pulmonary Disorder, and others.

According to the Centers for Disease Control and Prevention 2021 data, the age-adjusted prevalence of COPD among adults in the US in 2019 varied significantly by state, ranging from <4.5% in California, Colorado, Hawaii, Massachusetts, Minnesota, and Utah to >9% in Alabama, Arkansas, Kentucky, and West Virginia.

Furthermore, rising cases of Covid-19 in the country are projected to drive the demand for Pulmonology Devices in the coming years. For example, as of 14 February 2022, the WHO reported 143,190,545 confirmed cases of COVID-19 in the country.

Furthermore, the United States is the world's largest market, owing to sophisticated healthcare infrastructure and increased adoption of innovative non-invasive patient monitoring technology. In addition, prominent industry players such as Boston Scientific Corporation, Medtronic, and Pentax Medical, among others, are projected to enhance the market.

Furthermore, advanced product introductions and commercialization agreements between leading players are projected to drive the market. For example, in March 2021, Nonin Medical, Inc. introduced two new disposable products: a single-use wristband and a sensor for use with Nonin's WristOx2 3150 wrist-worn pulse oximeter (SpO2). Furthermore, in May 2021, California-based CorVent Medical reported that their Respond-19 ventilator had acquired CE mark clearance and was prepared to debut in Europe. The system got FDA emergency use authorization (EUA) for main critical care usage in December 2020, and it is predicted to drive market growth in Pulmonology Devices.

Directly Purchase a copy of the report with TOC : https://www.zionmarketresearch.com/toc/pulmonology-devices-market

As a result, the interaction of numerous factors such as a large patient population, favorable reimbursement policies, and new product launches in the region is likely to enhance the North America Pulmonology Devices market during the forecast period.

Key players in the Pulmonology Devices market include PENTAX Medical (Hoya Corporation), Boston Scientific Corporation, Medtronic, Ambu A/S, CONMED Corporation, Koninklijke Philips N.V., Cook, Medi-Globe GmbH, Getinge AB, ResMed, KARL STORZ SE & Co. KG, Verathon Inc, Olympus Corporation, Richard Wolf GmbH, FUJIFILM Corporation, Drägerwerk AG & Co. KGaA, Smiths Group PLC, SCHILLER AG, General Electric C.

On September 25, 2021, Emerson announced a partnership with BioBusiness, an Egyptian medical equipment manufacturer, to design and manufacture Ventilators using Emerson's ASCO™ valves and AVENTICS™ regulators for accurate pressure and gas flow control.
TytoCare Ltd debuted their artificial intelligence-powered Fingertip Pulse Oximeter (SpO2) on January 21, 2021, allowing for remote monitoring during the COVID crisis.
Max Ventilator signed a technical collaboration deal with Amptron Medical, a respiratory technology company based in the United States, on August 28, 2021, in order to meet worldwide standards.

The pulmonology device market plays a vital role in aiding patients with respiratory illnesses. This market research article explores the current state of the global pulmonology device market, highlighting key trends, growth drivers, challenges, and future prospects.

Market Size and Growth Trajectory:

• Market Value (2023): Estimates range from USD 10.2 billion to USD 14.7 billion.
• Projected CAGR (2024-2030): Market growth expectations vary, with predictions between 8.7% and 10.8%.
• Expected Market Size by 2030: Based on these estimations, the market size could reach USD 22.8 billion to USD 40.4 billion by 2030.

Growth Drivers:

• Rising Prevalence of Respiratory Diseases: The increasing incidence of chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea fuels demand for diagnostic and therapeutic pulmonary devices.
• Growing Geriatric Population: The aging population is more susceptible to respiratory problems, creating a larger patient pool for pulmonology devices.
• Technological Advancements: Development of innovative devices like portable spirometers and nebulizers with enhanced functionalities improves patient care and adherence to treatment plans.
• Focus on Home Healthcare: The increasing shift towards home healthcare settings drives demand for user-friendly and portable pulmonary devices.
• Rising Awareness and Early Diagnosis: Growing public awareness of respiratory diseases emphasizes the importance of early diagnosis and treatment, promoting the use of diagnostic devices.

Emerging Trends:

• Telemedicine Integration: Incorporating telemedicine capabilities into some pulmonary devices allows for remote patient monitoring and improved respiratory care delivery.
• Artificial Intelligence Integration: AI-powered devices for lung sound analysis and personalized treatment recommendations are gaining traction.
• Focus on Minimally Invasive Procedures: Development of minimally invasive diagnostic and therapeutic bronchoscopes for improved patient comfort and faster recovery times.
• Personalized Medicine: Tailoring treatment plans based on individual patient needs and genetic factors using advanced diagnostic tools.
• Growth in Wearable Respiratory Monitoring Devices: The increasing popularity of wearable devices for monitoring respiratory health, particularly for sleep apnea and COPD patients.

Market Challenges:

• High Costs and Reimbursement Challenges: The high cost of some advanced devices and potential reimbursement limitations can hinder accessibility for some patients.
• Need for Skilled Personnel: Operating and interpreting results from some pulmonary devices requires trained medical professionals.
• Stringent Regulatory Requirements: Navigating varying regulatory landscapes across regions regarding device approval and marketing can be challenging.
• Cybersecurity Concerns: The increasing integration of technology into devices necessitates robust cybersecurity measures to protect patient data.
• Counterfeit Products: Concerns about counterfeit pulmonary devices entering the market can pose safety risks and undermine trust.

Future Outlook:

The pulmonology device market is expected to witness significant growth, driven by:

• The rising burden of respiratory diseases and increasing focus on early diagnosis and treatment.
• Technological advancements leading to more user-friendly, efficient, and portable devices.
• Growing adoption of telemedicine and remote patient monitoring solutions.

Contact Us:
Zion Market Research
USA/Canada Toll Free: 1 (855) 465-4651
Newark: 1 (302) 444-0166
India: +91 7768 006 007, +91 7768 006 008
Skype no: +13479038971, +17187054574
Skype no. United Kingdom: +442032894158
Web: https://www.zionmarketresearch.com/
Blog: https://zmrblog.com/